Dr Marcus Gould
PHD Biochemistry, Oxford University, has established multi-national companies encompassing all aspects of CE mark, FDA, and Human Tissue Authority (HTA) activities. Marcus’s experience includes both pre-market and post-market activities, and he devises and implements regulatory strategies for CE Marking, US FDA applications and HTA submissions.
Marcus has designed, implemented and maintained Quality Management Systems for ISO 9001, ISO 13485, ISO 17025, ISO 15189, and HTA certification. He is